<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Rewalk Robotics Ltd — News on 6ix</title>
<link>https://6ix.com/company/rewalk-robotics-ltd</link>
<description>Latest news and press releases for Rewalk Robotics Ltd on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 25 Mar 2026 20:10:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/rewalk-robotics-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835910a78dffbe2df102499.webp</url>
<title>Rewalk Robotics Ltd</title>
<link>https://6ix.com/company/rewalk-robotics-ltd</link>
</image>
<item>
<title>Lifeward Successfully Closes on Strategic Partnership with Oramed</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-successfully-closes-on-strategic-partnership-with-oramed-1</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-successfully-closes-on-strategic-partnership-with-oramed-1</guid>
<pubDate>Wed, 25 Mar 2026 20:10:00 GMT</pubDate>
<description>HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that it has closed on the Company’s previously announced strategic partnership agreement with Oramed Pharmaceuticals Inc. (Nasdaq: ORMP). The transaction has positioned Lifeward as a diversified biomedical innovation compan</description>
</item>
<item>
<title>Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-reports-fourth-quarter-and-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-reports-fourth-quarter-and-full-year-2025-financial-results</guid>
<pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
<description>Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval; Lifeward gains new oral protein delivery technology platform Lifeward already executing new strategy through acquisition of powered upper-body exoskeleton technology Lower operating expenses and cash usage reflect improved operational efficiency HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 18, 2026 (GLOBE NEWSWIRE) -- Life</description>
</item>
<item>
<title>Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-receives-shareholder-approval-to-close-on-strategic-partnership-with-oramedcreating-diversified-biomedical-company-116</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-receives-shareholder-approval-to-close-on-strategic-partnership-with-oramedcreating-diversified-biomedical-company-116</guid>
<pubDate>Fri, 13 Mar 2026 12:00:00 GMT</pubDate>
<description>Positions Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed’s POD™ oral delivery technology expands Lifeward into biotech markets while Oramed funds the platform’s clinical development Provides Lifeward access to up to $47 million of capital HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform</description>
</item>
<item>
<title>Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-regains-compliance-with-nasdaq-minimum-bid-price-requirement</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-regains-compliance-with-nasdaq-minimum-bid-price-requirement</guid>
<pubDate>Wed, 11 Mar 2026 12:00:00 GMT</pubDate>
<description>HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 11, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced it has received a notification letter from The Nasdaq Stock Market LLC ("Nasdaq") confirming that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) ("Rule"). To re</description>
</item>
<item>
<title>Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-18-2026-26</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-18-2026-26</guid>
<pubDate>Tue, 10 Mar 2026 04:00:00 GMT</pubDate>
<description>MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader</description>
</item>
<item>
<title>Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-announces-collaboration-with-shirley-ryan-abilitylab-to-expand-access-for-the-rewalk-personal-exoskeleton</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-announces-collaboration-with-shirley-ryan-abilitylab-to-expand-access-for-the-rewalk-personal-exoskeleton</guid>
<pubDate>Mon, 02 Mar 2026 05:00:00 GMT</pubDate>
<description>Clinic days offered at Shirley Ryan AbilityLab, the #1 ranked rehabilitation hospital for 35 consecutive years, with the goal of accelerating personal</description>
</item>
<item>
<title>Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-to-acquire-powered-upper-body-exoskeleton-with-ai-capabilities-designed-to-restore-function-to-stroke-survivors</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-to-acquire-powered-upper-body-exoskeleton-with-ai-capabilities-designed-to-restore-function-to-stroke-survivors</guid>
<pubDate>Wed, 25 Feb 2026 05:00:00 GMT</pubDate>
<description>IP and technology acquisition is expected to be highly accretive and to advance Lifeward’s position as a diversified biomedical innovation companyWill Expand</description>
</item>
<item>
<title>Lifeward Announces Reverse Share Split</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-announces-reverse-share-split</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-announces-reverse-share-split</guid>
<pubDate>Fri, 20 Feb 2026 13:00:00 GMT</pubDate>
<description>Reverse split initiated as Lifeward enters strategic partnership agreement and repositions as MedTech innovation companyHUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical limitations or disabilities, today announced that effective with the open of the market on February 24, 2026, the Company will complete a 1-</description>
</item>
<item>
<title>Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifewards-rewalktm-personal-exoskeleton-now-covered-by-aetna-coverage-expands-to-include-three-of-the-largest-medicare-advantage-insurers</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifewards-rewalktm-personal-exoskeleton-now-covered-by-aetna-coverage-expands-to-include-three-of-the-largest-medicare-advantage-insurers</guid>
<pubDate>Tue, 17 Feb 2026 13:00:00 GMT</pubDate>
<description>Aetna joins Humana and United Healthcare in providing Medicare Advantage coverage for beneficiaries who meet medical necessity criteria for the ReWalk Personal Exoskeleton Together, these three national Medicare Advantage insurers represent approximately 16 million beneficiaries across the United States HUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to</description>
</item>
<item>
<title>Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-enters-transformative-strategic-investment-130000323</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-enters-transformative-strategic-investment-130000323</guid>
<pubDate>Tue, 13 Jan 2026 13:00:00 GMT</pubDate>
<description>Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential Up to $47 million strategic investment from Oramed and another investor is intended to provide Lifeward cash runway to profitability and diversify its portfolio across MedTech and BioTech Lifeward acquires Oramed’s clinical-stage Protein Oral Delivery (POD™) technology adding exposure to a large, long-term Biotech market opportunity POD™ targets the $600+ billion injectable drug</description>
</item>
<item>
<title>Lifeward Appoints Bob Marshall as Chairman of the Board</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-appoints-bob-marshall-chairman-210500923</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-appoints-bob-marshall-chairman-210500923</guid>
<pubDate>Fri, 19 Dec 2025 21:05:00 GMT</pubDate>
<description>MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical limitations or disabilities, announced today that its Board of Directors has appointed Bob Marshall as Chairman of the Board, effective January 1, 2026. He replaces Joseph Turk, who will transition off the Board in connection with his new position at Fre</description>
</item>
<item>
<title>Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-expands-international-distribution-rewalk-130000430</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-expands-international-distribution-rewalk-130000430</guid>
<pubDate>Wed, 17 Dec 2025 13:00:00 GMT</pubDate>
<description>Distribution agreement with Singapore-based Verita Neuro will provide patients the ReWalk Personal Exoskeleton as part of its multi-layered treatment modalities New delivery model for ReWalk will integrate in-patient training and rehabilitation to support clinical adoption in physical rehabilitation settings Over 7 million survivors of spinal cord injury (SCI) globally could potentially benefit from ReWalk, an estimated $1.75 billion total addressable market for Lifeward MARLBOROUGH, Mass., YOKN</description>
</item>
<item>
<title>Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-broadens-reimbursement-coverage-rewalk-130000140</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-broadens-reimbursement-coverage-rewalk-130000140</guid>
<pubDate>Wed, 03 Dec 2025 13:00:00 GMT</pubDate>
<description>Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for 47% of all Medicare Advantage enrollees This latest approval will help enhance timely access to cutting-edge personal exoskeleton solutions for individuals with spinal cord injury Reimbursement coverage is expected to give Lifeward stronger revenue and cash flow dynamics to scale growth MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 03, 2025 (GLOB</description>
</item>
<item>
<title>UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/unitedhealthcare-medicare-advantage-plan-issues-130000212</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/unitedhealthcare-medicare-advantage-plan-issues-130000212</guid>
<pubDate>Mon, 17 Nov 2025 13:00:00 GMT</pubDate>
<description>Approval marks continued progress in expanding reimbursement pathways and accelerating access to advanced personal exoskeleton technology for individuals with spinal cord injury.MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, announced today that it received its first prior authori</description>
</item>
<item>
<title>Lifeward Ltd. Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-ltd-reports-third-quarter-130000941</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-ltd-reports-third-quarter-130000941</guid>
<pubDate>Fri, 14 Nov 2025 13:00:00 GMT</pubDate>
<description>Record quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established Ongoing efficiency initiatives drive 16% year-over-year decrease in quarterly cash burn and 27% decrease in quarterly Non-GAAP operating loss Entered into $3.0 million loan agreement with Oramed Ltd. providing additional capital support MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innov</description>
</item>
<item>
<title>Lifeward to Report Third Quarter Financial Results on November 14, 2025</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-report-third-quarter-financial-120000388</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-report-third-quarter-financial-120000388</guid>
<pubDate>Mon, 10 Nov 2025 12:00:00 GMT</pubDate>
<description>MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its third quarter 2025 financial results before the markets open on Friday, November 14, 2025. Mark Grant, President and Chief Executive Officer, and Almog Adar, Chief Financial Officer, wi</description>
</item>
<item>
<title>First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/first-commercial-medicare-advantage-plan-123000705</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/first-commercial-medicare-advantage-plan-123000705</guid>
<pubDate>Tue, 09 Sep 2025 12:30:00 GMT</pubDate>
<description>Medicare Advantage claim processed in less than thirty days Additional progress with traditional Medicare claim approvals has accelerated timelines to payment in 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, announced today that it received its first payment from a commerci</description>
</item>
<item>
<title>Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-achieves-ce-mark-approval-123000961</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-achieves-ce-mark-approval-123000961</guid>
<pubDate>Mon, 08 Sep 2025 12:30:00 GMT</pubDate>
<description>Seventh generation of industry-leading ReWalk Exoskeleton is now cleared for commercial launch in the European UnionMARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, announced today that the company has received CE mark approval for the ReWalk 7 Personal Exoskeleton, clearing it for commerc</description>
</item>
<item>
<title>Lifeward Ltd. Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-ltd-reports-second-quarter-120000527</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-ltd-reports-second-quarter-120000527</guid>
<pubDate>Thu, 14 Aug 2025 12:00:00 GMT</pubDate>
<description>Achieves record number of ReWalk systems placed for Medicare beneficiaries since fee schedule established Third consecutive quarter of U.S. ReWalk pipeline growth with over 130 qualified leads in process Appoints new CEO and CFO to spearhead strategic change and accelerate growth MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of peo</description>
</item>
<item>
<title>Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership</title>
<link>https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-names-almog-adar-cfo-120000943</link>
<guid isPermaLink="true">https://6ix.com/company/rewalk-robotics-ltd/news/lifeward-names-almog-adar-cfo-120000943</guid>
<pubDate>Wed, 13 Aug 2025 12:00:00 GMT</pubDate>
<description>MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that Almog Adar, who previously served as the Company’s Vice President of Finance and Chief Accounting Officer, has been appointed as the Company’s new Chief Financial Officer. "I am thrilled to welcome Almog to the exe</description>
</item>
</channel>
</rss>